Artelo Biosciences (ARTL)
(Delayed Data from NSDQ)
$1.34 USD
0.00 (-0.13%)
Updated Apr 25, 2024 12:36 PM ET
After-Market: $1.31 -0.03 (-2.24%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 27% (69 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -1.05 | 2.87 | 60.00 |
Year Ago Quarter Estimate | -0.76 | -5.36 | 52.54 |
Next Quarter Estimate | -0.74 | 7.43 | 61.00 |
Next Year Estimate | -1.59 | 29.71 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 34.08 | 12.90 | 17.08 |
Next Year | 23.19 | 8.30 | 8.00 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 19.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 0.33 | 2.01 |
Price/Cash Flow (MRFY) | NA | 14.08 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -100.99% |
Return on Equity (TTM) | -61.68% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.